![6-[2-tert-butyl-4-(6-methyl-2-pyridyl)-4H-imidazol-5-yl]quinoxaline](https://static.cymitquimica.com/cas-image/288038-6-2-tert-butyl-4-6-methyl-2-pyridyl-4h-imidazol-5-yl-quinoxaline.png)
CAS: 356559-20-1 - 6-[2-tert-butyl-4-(6-methyl-2-pyridyl)-4H-imidazol-5-yl]quinoxaline
Formula:C21H21N5
InChI:InChI=1/C21H21N5/c1-13-6-5-7-16(24-13)19-18(25-20(26-19)21(2,3)4)14-8-9-15-17(12-14)23-11-10-22-15/h5-12,19H,1-4H3
- Synonyms:
- Sb525334
SB-525334
CAS:356559-20-1
Formula:
C21H21N5
Purity:
>98.0%(HPLC)
Color and Shape:
White to Yellow to Orange powder to crystal
Molecular weight:
343.43
Ref: 3B-B5776
| 10mg | 113.00 € | |
| 50mg | 381.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
SB-525334
CAS:356559-20-1
Formula:
C21H21N5
Purity:
≥ 98.0%
Color and Shape:
White to off-white or beige powder
Molecular weight:
343.42
Ref: 7W-GL1664
| 5mg | 125.00 € |
Estimated delivery in United States, on Monday 13 May 2024
SB 525334
CAS:356559-20-1
SB-525334 is a potent and selective inhibitor of the TGF-β1R and ALK5 (IC50: 14.3 nM).
Formula:
C21H21N5
Purity:
99.86%
Color and Shape:
Solid
Molecular weight:
343.42
Ref: TM-T1763
| 5mg | 63.00 € | |
| 10mg | 101.00 € | |
| 25mg | 177.00 € | |
| 50mg | 283.00 € | |
| 100mg | 446.00 € | |
| 200mg | 518.00 € | |
| 1ml*10 (DMSO) | 69.00 € |
Estimated delivery in United States, on Monday 13 May 2024
SB-525334
CAS:356559-20-1
SB-525334 is a synthetic compound that has been shown to be an inhibitor of the …
Formula:
C21H21N5
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
343.43 g/mol
Ref: 3D-FB43347
| 25mg | 101.00 € | |
| 50mg | 144.00 € | |
| 100mg | 195.00 € | |
| 250mg | 406.00 € | |
| 500mg | 587.00 € |
Estimated delivery in United States, on Friday 17 May 2024
Ref: TR-S154700
| 500mg | 9,017.00 € |
Estimated delivery in United States, on Tuesday 18 Jun 2024
Ref: AN-AG003MZ1
| 1g | Discontinued | |
| 5mg | Discontinued | |
| 10mg | Discontinued | |
| 50mg | Discontinued | |
| 100mg | Discontinued | |
| 250mg | Discontinued |
